Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Express Scripts
Farmers Insurance
Chinese Patent Office
Cipla
Cerilliant
QuintilesIMS
Julphar
Medtronic

Generated: May 20, 2018

DrugPatentWatch Database Preview

LODINE XL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Lodine Xl, and when can generic versions of Lodine Xl launch?

Lodine Xl is a drug marketed by Wyeth Pharms Inc and is included in one NDA.

The generic ingredient in LODINE XL is etodolac. There are twenty-three drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the etodolac profile page.
Drug patent expirations by year for LODINE XL
Medical Subject Heading (MeSH) Categories for LODINE XL
Synonyms for LODINE XL
(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid
(1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid
(RS)-2-(1,8-Diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid
[1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid
1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid
1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid
1,8-diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indole-1-acetic acid
1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid
1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid
1,8-Diethyl-1,3,4,9-tetrahydropyranol[3,4-b]indole-1-acetic acid
110781-63-0 (mono-hydrochloride salt)
2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid
2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid
2-{1,8-diethyl-1H,3H,4H,9H-pyrano[3,4-b]indol-1-yl}acetic acid
340E254
41340-25-4
AB00052194
AB00052194_17
AB0012214
AC-4231
AC1L1FN2
AKOS015838610
AN-12214
ANW-42024
AY 24236
AY-24,236
AY-24236
BC651843
BDBM50016799
BPBio1_000333
BRD-A74667430-001-05-3
BSPBio_000301
BSPBio_003138
C06991
CAS-41340-25-4
CCG-39005
CCRIS 3923
CE0096
CHEBI:4909
CHEMBL622
CPD000058443
CS-0832
CTK4I4719
D00315
D0N1WU
DB00749
DivK1c_000147
DR001052
DSSTox_CID_615
DSSTox_GSID_20615
DSSTox_RID_75691
DTXSID9020615
E 0516
E0858
Edolan
etodine
Etodlic Acid
etodolac
Etodolac (JP17/USP/INN)
Etodolac [USAN:BAN:INN]
Etodolac [USAN:INN:BAN]
Etodolac [USAN:USP:INN:BAN]
Etodolac for peak identification, European Pharmacopoeia (EP) Reference Standard
etodolac o
Etodolac, European Pharmacopoeia (EP) Reference Standard
Etodolac, United States Pharmacopeia (USP) Reference Standard
Etodolac(Lodine)
Etodolacetodolic acid
Etodolaco
Etodolaco [INN-Spanish]
Etodolacum
Etodolacum [INN-Latin]
Etodolic acid
Etodolsaure
EU-0100479
F2173-0681
FT-0607046
GTPL7185
HMS1568P03
HMS1921B09
HMS2092O20
HMS2095P03
HMS2231D04
HMS3259P10
HMS3261O20
HMS3374G09
HMS500H09
HY-76251
Hypen
IDI1_000147
K-8734
KBio1_000147
KBio2_001724
KBio2_004292
KBio2_006860
KBio3_002358
KBioGR_000680
KBioSS_001724
KS-0000000W
Lodine
Lodine (TN)
Lodine SR
Lopac0_000479
LP00479
LS-7393
MFCD00133313
MLS000028474
MLS001077315
MLS006011566
MolPort-001-759-084
NC00718
NCGC00015399-03
NCGC00015399-04
NCGC00015399-05
NCGC00015399-06
NCGC00015399-07
NCGC00015399-08
NCGC00015399-09
NCGC00015399-11
NCGC00015399-12
NCGC00015399-13
NCGC00015399-15
NCGC00015399-16
NCGC00016849-01
NCGC00089769-02
NCGC00089769-03
NCGC00089769-04
NCGC00089769-05
NCGC00089769-06
NCGC00089769-07
NCGC00259767-01
NCGC00261164-01
NINDS_000147
NNYBQONXHNTVIJ-UHFFFAOYSA-N
NSC 282126
NSC-282126
NSC-757821
NSC282126
NSC757821
Opera_ID_1774
Osteluc
Pharmakon1600-01501005
PL024570
Prestwick_209
Prestwick0_000231
Prestwick1_000231
Prestwick2_000231
Prestwick3_000231
Pyrano(3,4-b)indole-1-acetic acid, 1,3,4,9-tetrahydro-1,8-diethyl-
Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-
Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-(+-)-
Pyrano(3,4,b)indole-1-acetic acid, 1,3,4,9-tetrahydro-1,8-diethyl-
Pyrano[3, 1,8-diethyl-1,3,4,9-tetrahydro-
Pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-
Q-201099
RAK-591
Ramodar
RTR-036749
SAM002589968
SBB067257
SBI-0050463.P003
SCHEMBL3903
SMR000058443
SPBio_001374
SPBio_002222
Spectrum_001244
SPECTRUM1501005
Spectrum2_001387
Spectrum3_001429
Spectrum4_000410
Spectrum5_001347
SR-01000000100
SR-01000000100-2
Tedolan
Tox21_110644
Tox21_110644_1
Tox21_202218
Tox21_500479
TR-036749
Ultradol
Z1820178466
Zedolac

US Patents and Regulatory Information for LODINE XL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc LODINE XL etodolac TABLET, EXTENDED RELEASE;ORAL 020584-001 Oct 25, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc LODINE XL etodolac TABLET, EXTENDED RELEASE;ORAL 020584-003 Jan 20, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc LODINE XL etodolac TABLET, EXTENDED RELEASE;ORAL 020584-002 Oct 25, 1996 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for LODINE XL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc LODINE XL etodolac TABLET, EXTENDED RELEASE;ORAL 020584-002 Oct 25, 1996 ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc LODINE XL etodolac TABLET, EXTENDED RELEASE;ORAL 020584-001 Oct 25, 1996 ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc LODINE XL etodolac TABLET, EXTENDED RELEASE;ORAL 020584-003 Jan 20, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
Dow
Federal Trade Commission
McKesson
Farmers Insurance
Cipla
Chinese Patent Office
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.